Tetralogy of Fallot is a congenital heart defect that is caused by four characteristic anatomical abnormalities: pulmonary artery stenosis, interventricular septum, aorta located above both ventricles (dextroposition of the aorta), and hypertrophy of the right ventricle. This disease occurs as a result of abnormal formation of the heart in the early stages of embryonic development, which leads to insufficient blood supply to the lungs and disruption of normal oxygen metabolism in the body. Due to the lack of oxygen, patients with tetralogy of Fallot often experience cyanosis - blue discoloration of the skin and mucous membranes, especially in the area of the lips and nails. Tetralogy of Fallot is the most common cyanotic heart defect in newborns and requires early diagnosis and surgical treatment to correct the disorder.
History of the disease and interesting historical facts
Tetralogy of Fallot was first described in 1888 by French cardiologist Edward Fallot, after whom the condition was named. Interestingly, until modern diagnostic techniques such as echocardiography became available, many cases of tetralogy of Fallot went undiagnosed because the symptoms could be mistaken for general breathing or heart problems. The first cardiac surgeries for tetralogy of Fallot were performed in the 1940s, and surgical techniques have improved significantly since then. Tetralogy of Fallot has been the subject of much research, leading to a better understanding of the disease and improved treatment outcomes. In the 1980s, specialized centers for the treatment of heart disease were established, and minimally invasive surgery began to be developed.
Epidemiology
Tetralogy of Fallot is one of the most common cardiovascular defects, accounting for approximately 3-5% of all congenital heart defects. According to statistics, for every 10,000 newbornsREG 1-2 babies will have tetralogy of Fallot. The expected incidence rate is about 1 in 2,000-3,000 live births. The defect is more common in boys than in girls with a ratio of 3:1. It is now known that tetralogy of Fallot manifests itself not only in newborns, but also in older children, and, in rare cases, can be diagnosed in adults. Notably, patients with tetralogy of Fallot also have higher rates of other genetic syndromes, such as Down syndrome.
Genetic predisposition to this disease
It has now been established that tetralogy of Fallot has certain genetic roots. Mutations in genes such as NOTCH1, JAG1 and TBX1 may be the cause of this defect. Genetic testing shows that about 30-50% patients with tetralogy of Fallot have concomitant genetic disorders, in particular, such as 22q11.2 syndrome, or DiGeorge syndrome, which is also associated with various anomalies of the cardiovascular system. Genetic factors that contribute to the development of tetralogy of Fallot also include heredity. In children whose parents had cardiovascular defects, the risk of developing this disease increases significantly.
Risk factors for the development of this disease
Among the risk factors predisposing to the development of tetralogy of Fallot, the following can be distinguished:
- Environmental factors such as exposure of the expectant mother to toxic substances during pregnancy.
- Infections suffered by the mother during pregnancy, especially rubella and cytomegalovirus.
- Alcohol, drugs and smoking during pregnancy.
- Certain chronic maternal diseases, such as diabetes or phenylketonuria.
Although the exact mechanism by which heart defects form remains poorly understood, these factors may influence embryonic development, causing structural changes in the formation of the heart.
Diagnosis of this disease
The main symptoms of tetralogy of Fallot include cyanosis, shortness of breath, and difficulty breathing, especially with exertion. Some children may have a heart murmur. Laboratory tests for suspected tetralogy of Fallot include blood oxygen levels, which often show hypoxia. Radiologic tests, such as chest x-rays, may show characteristic changes, such as a pulmonary cap. Echocardiography is the main diagnostic test to visualize abnormalities in cardiac structure.
Differential diagnosis involves distinguishing tetralogy of Fallot from other cyanotic malformations such as tricuspid atresia or large vessel translocation. This process involves the use of an integrated approach of modern imaging techniques and assessment of associated clinical conditions.
Treatment
Treatment of tetralogy of Fallot usually involves surgery, which is performed early in life, usually in the first months of life. Surgery is aimed at correcting the anatomical changes. Pharmacological treatment may be used to manage symptoms such as shortness of breath or heart failure, but is not the mainstay of treatment. Other treatments may include antiarrhythmic drugs to treat cardiac arrhythmias in patients who have already had surgical correction. Ongoing monitoring of cardiac function and the possibility of complications are also important aspects.
List of medications used to treat this disease
The drugs used include:
- Digoxin to improve cardiac function.
- Diuretics to reduce swelling in heart failure.
- BETA blockers to control heart rhythm.
- Anticoagulants to prevent blood clots.
However, it is important to note that the focus of treatment is surgical correction.
Disease monitoring
Monitoring of patients with tetralogy of Fallot includes regular cardiac examinations, including echocardiography, at least once a year after surgery. The prognosis for most patients who undergo prophylactic surgery is considered good, but complications such as arrhythmia, valve insufficiency, or structural heart problems may occur. Complications may occur even many years after surgery, so maintaining regular contact with a cardiologist is important.
Age-related features of the disease
In newborns, tetralogy of Fallot often presents as severe cyanosis. In infancy, symptoms of difficulty breathing and shortness of breath during physical activity may be observed, especially during periods of rapid physical development. In adolescents and young adults, patients may be diagnosed with arrhythmia, and in older patients, heart failure. Surgery is usually necessary in early childhood, but there are cases of late operations due to chronic symptoms of the disease and lack of access to qualified medical care.
Questions and Answers
- What is Tetralogy of Fallot?
Tetralogy of Fallot is a congenital heart defect consisting of four anatomical changes that affect the normal functioning of the cardiovascular system. - What are the main symptoms of tetralogy of Fallot?
The main symptoms include cyanosis, shortness of breath and heart murmur. - How to diagnose tetralogy of Fallot?
Diagnostics include echocardiography, X-rays, and measurement of blood oxygen levels. - What treatment is needed for tetralogy of Fallot?
Treatment is most often surgical, aimed at correcting anatomical anomalies. - What is the prognosis for patients with tetralogy of Fallot?
With proper treatment and regular monitoring, most patients have a good prognosis for life, but complications may occur.
